Luminary Therapeutics
Minneapolis, US · Founded 2019 · Delaware corporation · 1 known investors
BiotechHealthtechMedical Devices
Founders & leadership
JL
Jeff LiterExecutive Officer, Director, Promoter
JH
James HaymakerDirector, Promoter
DL
David LargaespadaExecutive Officer, Director, Promoter
JR
Jeff RossDirector
JW
John WellsDirector
TL
Tracey LodieDirector
MC
Mark ChanceDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$1.4MraisedNov 2025 · 6 investors · BiotechnologyRule 506(b)
▶$1.4MraisedNov 2025 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Branden MoriarityDirector
- Mark ChanceDirector
- Tracey LodieDirector
- James HaymakerDirector, Promoter
- John WellsDirector
- Jeff RossDirector
- Jeff LiterExecutive Officer, Director, Promoter
- Offering amount
- $12.4M
- Amount sold
- $1.4M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJan 2025 · 49 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2025 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tracey LodieDirector
- Jeff LiterExecutive Officer, Director, Promoter
- Jeff RossDirector
- James HaymakerDirector, Promoter
- Mark ChanceDirector
- John WellsDirector
- Offering amount
- $5.5M
- Amount sold
- $5.2M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.2MraisedJan 2025 · 48 investors · BiotechnologyRule 506(b)
▶$5.2MraisedJan 2025 · 48 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeff RossDirector
- Jeff LiterExecutive Officer, Director, Promoter
- John WellsDirector
- James HaymakerDirector, Promoter
- Tracey LodieDirector
- Mark ChanceDirector
- Offering amount
- $5.9M
- Amount sold
- $5.2M
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$375KraisedNov 2021 · 3 investors · BiotechnologyRule 506(b)
▶$375KraisedNov 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jim HaymakerDirector
- David LargaespadaExecutive Officer, Director, Promoter
- Jeff LiterExecutive Officer, Director, Promoter
- John WellsDirector
- Tracey LodieDirector
- George CoxDirector
- Offering amount
- $1.5M
- Amount sold
- $375K
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$825KraisedFeb 2021 · 11 investors · Biotechnology
▶$825KraisedFeb 2021 · 11 investors · Biotechnology
Officers, directors & promoters on the filing
- Jim HaymakerDirector
- Tracey LodieDirector
- George CoxDirector
- John WellsDirector
- Jeff LiterExecutive Officer, Director, Promoter
- David LargaespadaExecutive Officer, Director, Promoter
- Offering amount
- $1M
- Amount sold
- $825K
- First sale
- Jan 2021
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 04
▶$1.5MraisedNov 2019 · 11 investors · BiotechnologyRule 506(b)
▶$1.5MraisedNov 2019 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David LargaespadaExecutive Officer, Director, Promoter
- Jeff LiterExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Oct 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.